返回 Agendas
Session 6 Track 4: Mergers and Acquisitions: Implications for RIM
Session Chair(s)
Jake Doran
Managing Director
List Innovations, United States
Attendees will be informed of the various implications mergers & acquisitions have on the Regulatory Information Management (RIM) environment. The session will be broken down into four areas:
1.) State of the Union regarding M&A in Life Sciences
2.) A specific look at Sanofi and how their history of acquisitions impacts various systems and processes within Regulatory Operations.
3.) A call to action for health authorities, vendors, and industry to address the complexities of the M&A environment.
4.) Open panel discussion with active audience participation.
Speaker(s)
Global Regulatory Operations Platform and Technology Enablement
Tobias Massa, PHD
Sanofi US, United States
Vice President, Global Regulatory Operations
Can You Help Us Out? A Call to Action for Health Authorities, Vendors and Industry to Address the Complexities of the M&A Environment
Matt Neal, MA
BeOne Medicines USA, Inc., United States
Executive Director, Global Regulatory Operations Strategy & Innovation